Our Healthcare Director Henk Joos was present at the East-West Biopharma Summit, where he participated in the Scene Setter panel discussion hosted by Simone Fishburn (BioCentury) together with Debra Yu (LianBio), Chris Carpenter (Sofinnova) and Thomas Herget (Merck Group).
Besides the panel, which can be found on the partnering platform for registered attendees, Henk also participated in the podcast of BioCentury.
The popular “BioCentury This Week” podcast goes on the road to the East-West Biopharma Summit with special guests joining podcast host Jeff Cranmer to discuss highlights of the day.
As China’s biopharma companies experience their first “biotech winter,” they should be engaged in active portfolio management, stopping projects that will not meet their investors’ expectations, Agio Capital General Manager Henk Joos said on BioCentury This Week. On a special East-West Summit edition of the podcast, Joos and Immune-Onc Therapeutics founder and CEO Charlene Liao discussed pipeline prioritization and other company survival tactics during today’s difficult financing environment.
Click here to listen to the podcast.
Subject: AGIO Finance
